Research Article
Furlough CL and Eskandari MK
Abstract
Background: Rupture in Descending Thoracic Aortic Aneurysms (rDTAA) is a fatal complication. Open repair has long been the traditional standard of treatment; however, thoracic endovascular repair (TEVAR) has become increasingly popular to treat this complication. Even with continued surgical advances, open repair (OR) remains associated with high morbidity and mortality. The introduction of TEVAR and its common use in the treatment of rDTAA has raised the question of the possible superiority of one over the other. Purpose: This review discusses specific considerations in rDTAA repair including initial management, complications, and results of OR and TEVAR. Conclusion: Despite lacking evidence, TEVAR is often first choice treatment for rDTAA and leads to early survival; however, it has specific device related complications that affect long term outcomes.